Abingworth
PE / VC · London · United Kingdom
Stages
Investment region
Industries
Profile
Abingworth is a life sciences investor based in London, New York, and San Francisco, founded in the 1980s. With a long history in biotech investing, the firm has expanded transatlantically, supporting over 200 companies with their team of 28 professionals. Known for their experience in navigating startups through various challenges, Abingworth takes pride in their strategic support to portfolio companies through unique approaches such as Venture Investments in Public Equities (VIPEs) and Clinical Co-Development. Abingworth invests in life sciences and healthcare sectors, focusing on biotechnology and pharmaceuticals. They participate in seed, early, and development-stage funding, with investments primarily in North America and Europe. The firm manages multiple funds including Abingworth Bioventures funds and Clinical Co-Development funds, with recent fundraises totaling over $1 billion. Abingworth's presence in key biotech hubs enables direct interaction with talented entrepreneurs. Noteworthy portfolio companies include Prism - precision medicine, F2G - antifungal treatments, GammaDelta - oncology therapies, and Inflazome - inflammasome inhibitors. Abingworth has a record of taking companies through IPOs and strategic transactions, utilizing their deep life sciences expertise.
担当者 (2)
| Name | Title | 電話 | ||
|---|---|---|---|---|
| Managing Partner, Chief Investment Officer | — | — | — | |
| Managing Partner | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.